Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune diseases affecting the skin may experience those adverse reactions on a delay - sometimes even after treatment has concluded. In a study...
Original Article: Cancer patients may experience delayed skin effects of anti-PD-1 therapy